Free Trial

Dr. Hönle (ETR:HNL) Shares Down 1.3% - Here's What Happened

Dr. Hönle logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Shares down 1.3%: Dr. Hönle fell 1.3% on Thursday to €9.44, trading as low as €9.36 on a mid-day volume of 2,844 shares (previous close €9.56).
  • Key financials: The firm shows a debt-to-equity of 63.28, limited liquidity (quick ratio 0.85, current ratio 1.77), market cap ≈ $56.3M, a negative PE (-4.24) and a beta of 1.45.
  • Business profile: Dr. Hönle supplies industrial UV technologies across three segments—Adhesives, Equipment & Systems, and Glass & Lamps—serving electronics, automotive, medical, coatings and disinfection applications.
  • Five stocks we like better than Dr. Hönle.

Dr. Hönle AG (ETR:HNL - Get Free Report)'s share price fell 1.3% during trading on Thursday . The stock traded as low as €9.36 and last traded at €9.44. 2,844 shares traded hands during mid-day trading, The stock had previously closed at €9.56.

Dr. Hönle Stock Down 1.3%

The company has a debt-to-equity ratio of 63.28, a quick ratio of 0.85 and a current ratio of 1.77. The firm's 50-day moving average is €9.16 and its 200 day moving average is €8.28. The firm has a market capitalization of $56.26 million, a PE ratio of -4.24, a price-to-earnings-growth ratio of -0.39 and a beta of 1.45.

Dr. Hönle Company Profile

(Get Free Report)

Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dr. Hönle Right Now?

Before you consider Dr. Hönle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Hönle wasn't on the list.

While Dr. Hönle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines